Texas Gov. Greg Abbott asked the federal government for $11 billion as a reimbursement for the border security measures he ...

FOX Business' Taylor Riggs takes a look at shares from Texas Instruments, Novo Nordisk and Intuitive Surgical on 'The Claman ...

Donald Trump insisted he was serious in his determination to take over Greenland in a fiery telephone call with Denmark’s ...

Mr Trump spoke to Mette Frederiksen, the Danish premier, for 45 minutes last week. The White House has not commented on the ...

Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...

Novo Nordisk’s NVO amycretin, which targets GLP-1 and amylin in one molecule, generated 24% placebo-adjusted weight loss in a ...

A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the ...

Novo Nordisk was slammed by a U.K. trade group for not disclosing payments to health and patient groups, according to a draft ...

Novo Nordisk said a Phase 1b/2a clinical trial of amycretin, which activates both the GLP-1 and amylin receptors to help manage blood sugar and weight, achieved weight loss of 22% on a 20 milligram ...

Novo Nordisk A/S rose the most in a month after an experimental shot delivered as much as 22% weight loss in an early-stage ...